• P O Gubbins, D J Occhipinti, and L H Danziger.
• Department of Pharmacy Practice, University of Arkansas for Medical Sciences College of Pharmacy, Little Rock 72205-7122.
• Pharmacotherapy. 1994 Jul 1; 14 (4): 463-70.

Study ObjectiveTo determine the influence of treatment on the microbiologic outcome of funguria.DesignRetrospective case series.SettingA 300-bed tertiary care teaching hospital in a large metropolitan area.Subjects141 hospitalized patients, 18 years of age or older, with at least one urine culture positive (> or = 10(2) cfu/ml) for fungi.InterventionsRetrospective review of medical records to determine the microbiologic outcome of funguria.Main ResultsFunguria developed rapidly in individuals with known predisposing factors. Urinalysis did not routinely detect the presence of fungi or pyuria. Symptoms such as fever, dysuria, and frequency were generally absent. Funguria persisted whether it was due to Candida albicans or nonalbicans species. There were no statistical differences in the microbiologic outcomes of treated and untreated funguria.ConclusionsFunguria is a rapidly developing, often benign and persistent process. Minimizing predisposing risks, such as removing indwelling urinary catheters, is beneficial in its management. Pharmacologic treatment of funguria due to C. albicans or non-albicans species does not influence the microbiologic outcome.

29 keywords...

hide…